Ardea Biosciences Inc (NASDAQ:RDEA) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Felix Baker Other companies: BeOne Medicines Ltd. Class A (Director · Since at least Nov 6, 2026); Denali Therapeutics Inc. (Director · Since at least Jun 3, 2025); Replimune Group, Inc. (Director · Since at least Mar 5, 2025); Bicycle Therapeutics PLC (Director · Since at least Apr 18, 2024); Kymera Therapeutics, Inc. (Chairman · Since at least Mar 28, 2024); vTv Therapeutics Inc. (Director · Since at least Feb 27, 2024); Madrigal Pharmaceuticals, Inc. (Director · Since at least Jun 15, 2023); TScan Therapeutics, Inc. (Director · Since at least Jul 15, 2021); DBV Technologies SA (Director · Since at least Jan 1, 2021); Prelude Therapeutics Incorporated (Director · Since at least Mar 27, 2020); IGM Biosciences Inc (Director · Since at least Sep 17, 2019); Kodiak Sciences Inc (Director · Since at least Oct 3, 2018); Kiniksa Pharmaceuticals International, plc (Lead Director · Since at least Feb 9, 2018); ACADIA Pharmaceuticals Inc. (Director · Since at least Jan 18, 2013); Incyte Corporation (Director · Since at least Jan 4, 2008); Immunocore Holdings plc (Director · May 28, 2024 – May 15, 2025 · Past); Spyre Therapeutics, Inc. (Director · Feb 23, 2021 – Jun 8, 2021 · Past); Talis Biomedical Corp (Director · Nov 2, 2020 – Jun 9, 2023 · Past); Zymeworks Inc. (Director · Mar 16, 2020 – May 8, 2020 · Past); Neurogene Inc. (Director · May 8, 2017 – Dec 18, 2023 · Past); Alexion Pharmaceuticals Inc (Director · Jun 22, 2015 – May 14, 2020 · Past); Aceragen Inc. (Director · Mar 10, 2014 – Apr 1, 2019 · Past); Synageva BioPharma Corp (Director · Aug 14, 2007 – Jun 22, 2015 · Past); Neurogen Corp (Director · Jun 7, 2007 – Jul 25, 2008 · Past); Seagen Inc (Director · May 25, 2007 – Dec 14, 2023 · Past); Genomic Health Inc (Director · May 21, 2007 – Oct 1, 2019 · Past) | Director · Feb 8, 2010 – Jun 19, 2012 · Past |
| Julian Baker Other companies: Denali Therapeutics Inc. (Director · Since at least Jun 3, 2025); Replimune Group, Inc. (Director · Since at least Mar 5, 2025); Bicycle Therapeutics PLC (Director · Since at least Apr 18, 2024); Kymera Therapeutics, Inc. (Director · Since at least Mar 28, 2024); vTv Therapeutics Inc. (Director · Since at least Feb 27, 2024); Madrigal Pharmaceuticals, Inc. (Director · Since at least Jun 15, 2023); TScan Therapeutics, Inc. (Director · Since at least Jul 15, 2021); DBV Technologies SA (Director · Since at least Jan 1, 2021); Prelude Therapeutics Incorporated (Director · Since at least Mar 27, 2020); IGM Biosciences Inc (Director · Since at least Sep 17, 2019); Kodiak Sciences Inc (Director · Since at least Oct 3, 2018); Kiniksa Pharmaceuticals International, plc (Director · Since at least Feb 9, 2018); ACADIA Pharmaceuticals Inc. (Director · Since at least Jan 18, 2013); Incyte Corporation (Managing Partner, Baker Brothers Investments | Chairman, Incyte · Since at least Apr 25, 2006); Immunocore Holdings plc (Director · May 28, 2024 – May 15, 2025 · Past); Spyre Therapeutics, Inc. (Director · Feb 23, 2021 – Jun 8, 2021 · Past); Talis Biomedical Corp (Director · Nov 2, 2020 – Jun 9, 2023 · Past); Zymeworks Inc. (Director · Mar 16, 2020 – May 8, 2020 · Past); Neurogene Inc. (Director · May 8, 2017 – Dec 18, 2023 · Past); Alexion Pharmaceuticals Inc (Director · Jun 22, 2015 – May 14, 2020 · Past); Aceragen Inc. (Director · Mar 10, 2014 – Apr 1, 2019 · Past); Seagen Inc (Director · Jun 9, 2006 – Dec 14, 2023 · Past); Innoviva, Inc. (Director · Apr 26, 2006 – Apr 26, 2006 · Past); Genomic Health Inc (Director · Apr 25, 2006 – Oct 1, 2019 · Past); Synageva BioPharma Corp (Director · Apr 25, 2006 – Jun 22, 2015 · Past); Neurogen Corp (Director · Mar 15, 2006 – Dec 15, 2009 · Past) | Director · Apr 6, 2010 – Jun 19, 2012 · Past |
| Wendy L Dixon Other companies: Zevra Therapeutics, Inc. (Director · Since at least Apr 25, 2023); Iovance Biotherapeutics, Inc. (Director · Jun 10, 2022 – Jun 10, 2022 · Past); Black Diamond Therapeutics, Inc. (Director · Apr 6, 2022 – Mar 15, 2024 · Past); Arvinas, Inc. (Director · Jun 29, 2020 – Jun 15, 2023 · Past); Sesen Bio Inc (Director · Jun 12, 2018 – Jun 19, 2019 · Past); Voyager Therapeutics, Inc. (Director · Jan 1, 2017 – Jun 4, 2020 · Past); Eleven Biotherapeutics Inc (Director · Oct 22, 2014 – May 19, 2017 · Past); Bluebird bio Inc (Director · Jun 18, 2013 – Nov 11, 2021 · Past); Alkermes plc (Director · Jan 13, 2011 – Jun 14, 2022 · Past); Furiex Pharmaceuticals Inc (Director · May 27, 2010 – Jul 2, 2014 · Past); Incyte Corporation (Director · May 21, 2010 – Mar 31, 2022 · Past); Orexigen Therapeutics Inc (Director · Apr 20, 2010 – Jun 9, 2015 · Past); Dentsply Sirona Inc. (Director · Jul 31, 2007 – Jul 8, 2010 · Past); Bristol-Myers Squibb Company (CMO & Pres, Global Marketing · Mar 7, 2006 – May 22, 2006 · Past) | Director · Apr 6, 2011 – Jun 19, 2012 · Past |
| Stephen Davis Other companies: Bellicum Pharmaceuticals Inc (Director · Jul 13, 2015 – Jan 3, 2023 · Past); ACADIA Pharmaceuticals Inc. (CEO, Director · Jul 15, 2014 – Aug 16, 2024 · Past); Furiex Pharmaceuticals Inc (Director · May 24, 2013 – Jul 2, 2014 · Past); Heron Therapeutics, Inc. (Director · Feb 17, 2010 – Dec 16, 2022 · Past); Synageva BioPharma Corp (Director · Jun 27, 2007 – Jun 22, 2015 · Past); Neurogen Corp (President, CEO, Director · Dec 15, 2006 – Jul 25, 2008 · Past) | EVP & COO · Apr 6, 2010 – Jun 19, 2012 · Past |
| Craig Johnson Other companies: Aurinia Pharmaceuticals Inc (Board Director · Since at least Nov 7, 2024); Heron Therapeutics, Inc. (Lead Independent Director · Since at least Jan 10, 2014); La Jolla Pharmaceutical Co (Director · Oct 14, 2013 – Aug 22, 2022 · Past); PURE Bioscience (Chief Financial Officer · Aug 1, 2011 – Aug 1, 2011 · Past); DMK Pharmaceuticals Corporation (Director · Feb 10, 2011 – Oct 16, 2013 · Past) | Director · Jan 3, 2011 – Jun 19, 2012 · Past |
| Kimberly Manhard Other companies: Connect Biopharma Holdings Limited (CHIEF DEVELOPMENT OFFICER · Since at least Nov 5, 2026); Inhibrx Biosciences, Inc. (Director · Since at least May 24, 2024); Inhibrx Inc (Director · Aug 18, 2020 – May 30, 2024 · Past); Heron Therapeutics, Inc. (EVP, Drug Development · Jan 10, 2014 – Apr 13, 2023 · Past) | SVP, Regulatory & Dev Ops · Oct 28, 2011 – Jun 19, 2012 · Past |
| Henry J Fuchs Other companies: Genomic Health Inc (Director · Sep 17, 2013 – Nov 8, 2019 · Past); BioMarin Pharmaceutical Inc. (President, Worldwide R&D · Mar 2, 2009 – Sep 13, 2024 · Past); Onyx Pharmaceuticals Inc (EVP & Chief Medical Officer · Mar 1, 2006 – Nov 18, 2008 · Past) | Director · Feb 13, 2006 – Jun 19, 2012 · Past |
| David T Hagerty Other companies: Histogen Inc (EVP, Clinical Development · Oct 1, 2014 – Feb 7, 2019 · Past) | Senior VP & CMO · Dec 16, 2011 – Jun 19, 2012 · Past |
| Denis Hickey | Chief Financial Officer · Apr 26, 2007 – Dec 13, 2007 · Past |
| Patrick M O'Connor | Sr. VP, R & Pre-Clin.Dev., CSO · Jul 26, 2007 – Jul 26, 2007 · Past |